機構銀行市場 - 2025-2030 年預測

機構銀行市場預計將從 2025 年的 21.28 億美元成長到 2030 年的 32.86 億美元，複合年成長率為 9.07%。

由於醫療和研究領域對新鮮樣本和組織的需求不斷成長，全球組織庫市場正在經歷顯著成長。組織庫收集並儲存生物樣本以備將來使用，對醫療保健和研究領域的進步至關重要，尤其是在慢性病治療和組織再生領域。本摘要基於2024年後的市場發展，為產業專家提供了關鍵的成長動力和地理趨勢。

市場成長動力

慢性病治療中組織需求的增加

在治療癌症等慢性疾病時對組織的需求不斷成長，這是全球組織庫市場的主要驅動力。組織庫提供再生療法的重要檢體，可應對日益成長的慢性疾病盛行率。在美國，組織庫網路非常健全，根據美國組織庫協會 (AATB) 報告，美國約有 58 個經過認證的組織庫。這些組織庫均經過美國食品藥物管理局(FDA) 認證，確保符合嚴格的監管標準。血液組織和細胞佔據市場主導地位，反映了它們在再生療法中的重要角色。政府（尤其是美國）支持在醫療保健中使用組織庫，這進一步推動了市場的擴張。

研發進度

專注於組織再生和慢性病治療的研發活動激增，推動組織庫市場的發展。諸如應用幹細胞開發各種組織等創新標誌著醫學健康研究領域的重大突破。包括艾爾建和漢密爾頓在內的行業巨頭正在大力投資組織工程，以加強基於組織的治療方法的開發和應用。這些研發工作使組織庫能夠擴大其覆蓋範圍，並滿足對先進治療解決方案日益成長的需求，從而推動市場成長。

地理視角

北美市場佔有率壓倒性佔有率

北美佔據全球組織庫市場最大佔有率，這得益於其完善的組織庫網路和活躍的組織工程研發。由於主要市場參與者的存在以及慢性病的高發病率，該地區對組織療法的需求日益成長。尤其是美國，憑藉其先進的醫療基礎設施、經FDA認證的組織庫以及政府的支持性政策，在組織庫市場中處於領先地位。這些因素共同作用，使北美成為技術創新和市場成長的中心。

結論

受慢性病治療對組織日益成長的需求以及組織工程研究的進步推動，全球組織庫市場預計將持續擴張。北美地區憑藉其強大的認證組織庫網路以及主要參與者的大量投資，仍然保持市場領先地位。隨著醫療和研究領域對組織庫的依賴日益加深，預計該市場將保持成長勢頭，為醫療保健和生物技術行業的相關人員帶來重大機會。

本報告的主要優點

• 深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
• 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透。
• 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
• 可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
• 適用範圍廣：對於新興企業、科學研究機構、顧問公司、中小企業、大型企業都有利且划算。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

• 2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
• 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
• 競爭定位、策略和市場佔有率分析
• 各細分市場和地區（包括國家）的收益成長和預測分析

公司簡介

目錄

第1章執行摘要

第2章市場概述

• 市場概覽
• 市場定義
• 研究範圍
• 市場區隔

第3章 商業景氣

• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析
• 產業價值鏈分析
• 政策法規
• 策略建議

第4章 技術展望

第5章 機構銀行市場（依機構類型）

• 介紹
• 角膜
• 皮膚
• 骨
• 心臟瓣膜
• 其他

第6章。按儲存類型分類的機構銀行市場

• 介紹
• 冷凍
• 快速冷凍
• 其他

第7章 機構銀行市場（按應用）

• 介紹
• 治療
• 研究與開發
• 組織工程
• 其他

第8章 機構銀行市場（依最終用戶）

• 介紹
• 醫院
• 研究和學術機構
• 其他

第9章 機構銀行市場（按地區）

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 其他

第10章競爭格局及分析

• 主要企業和策略分析
• 市場佔有率分析
• 合併、收購、協議和合作
• 競爭儀錶板

第11章 公司簡介

• Life Link Tissue Bank
• Alamo Biologics
• ViaCord（Revvity Inc.）
• DCI Donor Services Tissue Bank
• Thermo Fisher Scientific Inc.
• Azenta Life Sciences
• Tecan Group Ltd.
• BioLife Solutions, Inc.
• PHC Corporation
• Rokit Healthcare

第12章 附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要利益
• 調查方法
• 簡稱

The tissue banking market is expected to grow from USD 2.128 billion in 2025 to USD 3.286 billion in 2030, at a CAGR of 9.07%.

The global tissue banking market is experiencing significant growth, driven by increasing demand for fresh specimens and tissues in medical and research applications. Tissue banks, which collect and store biological specimens for future use, are pivotal in supporting advancements in healthcare and research, particularly in the treatment of chronic diseases and tissue regeneration. This summary highlights key growth drivers and geographical trends based on market developments from 2024 onward, tailored for industry experts.

Market Growth Drivers

Rising Demand for Tissue in Chronic Disease Treatment

The escalating need for tissues to treat chronic conditions, such as cancer, is a primary driver of the global tissue banking market. Tissue banks provide critical specimens used in regenerative therapies, addressing the growing prevalence of chronic disorders. In the United States, the tissue banking network is robust, with approximately 58 accredited tissue banks, as reported by the American Association of Tissue Banks (AATB). These banks are certified by the U.S. Food and Drug Administration (FDA), ensuring compliance with stringent regulatory standards. Blood tissues and cells dominate the market, reflecting their critical role in regenerative treatments. Government support, particularly in the U.S., further accelerates market expansion by promoting tissue bank utilization in healthcare.

Advancements in Research and Development

The surge in research and development (R&D) activities focused on tissue regeneration and chronic disease treatment is propelling the tissue banking market forward. Innovations, such as stem cell applications for developing various tissues, represent significant breakthroughs in the medical and health research sectors. Major industry players, including Allergan and Hamilton Companies, are investing heavily in tissue engineering, enhancing the development and application of tissue-based therapies. These R&D efforts are expanding the scope of tissue banks, enabling them to meet the growing demand for advanced therapeutic solutions and driving market growth.

Geographical Outlook

North America's Dominant Market Share

North America holds the largest share of the global tissue banking market, driven by a well-established network of tissue banks and robust R&D in tissue engineering. The region benefits from the presence of leading market players and a high incidence of chronic diseases, which increase the demand for tissue-based treatments. The U.S., in particular, leads due to its advanced healthcare infrastructure, FDA-accredited tissue banks, and supportive government policies. These factors collectively position North America as the epicenter of tissue banking innovation and market growth.

Conclusion

The global tissue banking market is poised for continued expansion, fueled by the rising need for tissues in chronic disease treatment and advancements in tissue engineering research. North America remains the market leader, supported by a strong network of accredited tissue banks and significant investments from key players. As the medical and research sectors increasingly rely on tissue banks, the market is expected to maintain its growth trajectory, offering substantial opportunities for stakeholders in the healthcare and biotechnology industries.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries

Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Tissue Banking Market Segmentation

By Tissue Type

• Cornea
• Skin
• Bones
• Heart Valves
• Others

By Storage Type

• Cryopreservation
• Deep-Freezing
• Others

By Application

• Therapeutic
• Research & Development
• Tissue Engineering
• Others

By End-User

• Hospitals
• Research & Academic Institutes
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• UK
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Taiwan
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. TISSUE BANKING MARKET BY TISSUE TYPE

• 5.1. Introduction
• 5.2. Cornea
• 5.3. Skin
• 5.4. Bones
• 5.5. Heart Valves
• 5.6. Others

6. TISSUE BANKING MARKET BY STORAGE TYPE

• 6.1. Introduction
• 6.2. Cryopreservation
• 6.3. Deep-Freezing
• 6.4. Others

7. TISSUE BANKING MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Therapeutic
• 7.3. Research & Development
• 7.4. Tissue Engineering
• 7.5. Others

8. TISSUE BANKING MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Research & Academic Institutes
• 8.4. Others

9. TISSUE BANKING MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Life Link Tissue Bank
• 11.2. Alamo Biologics
• 11.3. ViaCord (Revvity Inc.)
• 11.4. DCI Donor Services Tissue Bank
• 11.5. Thermo Fisher Scientific Inc.
• 11.6. Azenta Life Sciences
• 11.7. Tecan Group Ltd.
• 11.8. BioLife Solutions, Inc.
• 11.9. PHC Corporation
• 11.10. Rokit Healthcare

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations